Shi Qing Cheng
Direttore/Membro del Consiglio presso Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Posizioni attive di Shi Qing Cheng
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
 Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | 18/11/2021 | - |
Storia della carriera di Shi Qing Cheng
Formazione di Shi Qing Cheng
| Peking University | Graduate Degree |
| Renmin University of China | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Cina | 4 |
Posizioni
| Director/Board Member | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
 | Health Technology |
- Borsa valori
- Insiders
- Shi Qing Cheng
- Esperienza
